|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Prepaids and deposits | ||||||||||||||||||||
| Supplies inventories, net | ||||||||||||||||||||
| Receivables | ||||||||||||||||||||
| Equity investment securities | ||||||||||||||||||||
| Interest receivable | ||||||||||||||||||||
| Accounts receivable | ||||||||||||||||||||
| Other receivables | ||||||||||||||||||||
| Receivables, net | ||||||||||||||||||||
| Current assets | ||||||||||||||||||||
| Property, plant, and equipment, net | ||||||||||||||||||||
| Property, plant, and equipment and assets held-for-sale, net | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Assets held-for sale | ||||||||||||||||||||
| Prepaids, non-current | ||||||||||||||||||||
| Prepaids – Note 3 | ||||||||||||||||||||
| Equity investment securities, non-current | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Accounts payable, accrued expenses, and other liabilities | ||||||||||||||||||||
| Contract liabilities | ||||||||||||||||||||
| Asset retirement obligation | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Debt, net | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Deferred gain on sale of royalty | ||||||||||||||||||||
| Asset retirement obligation, non-current | ||||||||||||||||||||
| Warrant liabilities – Notes 10 and 14 | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ equity | ||||||||||||||||||||
| Common stock, $0.0001 par value; 1,400,000,000 shares authorized; 93,130,394 issued and outstanding at June 30, 2026, and 83,025,384 issued and outstanding at December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
Loading...
